studi
measur
antihav
antihb
respons
elderli
peopl
mean
age
year
applic
twinrix
short
person
older
year
exhibit
seroprotect
hepat
b
hepat
increas
age
antibodi
respons
vaccin
even
less
pronounc
howev
even
seem
vaccin
failur
booster
prove
effect
conclus
drawn
applic
combin
hepat
b
vaccin
twinrix
use
effect
elderli
person
recommend
measur
antibodi
respons
antigen
elderli
peopl
ensur
protect
particularli
import
increas
number
elderli
peopl
travel
variou
region
world
need
adequ
protect
conclus
drawn
quit
alarm
need
scrutini
interpret
chang
age
immun
system
observ
impair
antibodi
respons
tetanu
diphtheria
pneumococc
tickborn
enceph
vaccin
well
hepat
b
vaccin
correctli
cite
wolter
et
al
describ
elderli
peopl
determin
antibodi
level
recommend
elderli
peopl
vaccin
new
vaccin
previou
contact
common
basi
observ
appar
lie
find
involut
thymu
almost
complet
age
year
host
depend
cell
pool
gener
earlier
life
chang
cell
repertoir
eventu
observ
anoth
interest
observ
concern
rate
disappear
antibodi
two
phase
antibodi
declin
fast
slow
phase
observ
hepat
well
hepat
b
antibodi
respons
measur
quantit
result
may
differ
consider
depend
whether
blood
sampl
drawn
middl
fast
phase
slow
phase
remark
stress
also
perform
retrospect
studi
antibodi
respons
hepat
b
applic
combin
hepat
b
vaccin
twinrix
comparison
two
monoval
hepat
b
vaccin
g
antigen
content
younger
elderli
peopl
also
found
increas
age
antibodi
titer
immun
hepat
b
antigen
tend
lower
result
elderli
peopl
howev
differ
wolter
et
al
studi
correspond
time
admiss
diagnosi
made
epidemiolog
clinic
ground
diagnost
test
yet
avail
would
like
add
subsequ
perform
sar
serolog
posit
index
passeng
flight
attend
thu
confirm
inflight
transmiss
sar
serolog
also
posit
wife
index
passeng
howev
motherinlaw
neg
sar
serolog
later
clear
suffer
sar
preiser
w
person
commun
remain
unclear
motherinlaw
despit
prolong
close
contact
longhaul
flight
also
prior
flight
stay
new
york
later
hospit
frankfurt
develop
sar
wherea
flight
attend
infect
brief
contact
factor
determin
transmiss
suscept
sar
coronaviru
continu
constitut
import
area
research
wildersmith
leong
hn
villacian
js
inflight
transmiss
sever
acut
respiratori
syndrom
sar
case
report
studi
measur
antihav
antihb
respons
elderli
peopl
mean
age
year
applic
twinrix
short
person
older
year
exhibit
seroprotect
hepat
b
hepat
increas
age
antibodi
respons
vaccin
even
less
pronounc
howev
even
seem
vaccin
failur
booster
prove
effect
conclus
drawn
applic
combin
hepat
b
vaccin
twinrix
use
effect
elderli
person
recommend
measur
antibodi
respons
antigen
elderli
peopl
ensur
protect
particularli
import
increas
number
elderli
peopl
travel
variou
region
world
need
adequ
protect
conclus
drawn
quit
alarm
need
scrutini
interpret
chang
age
immun
system
observ
impair
antibodi
respons
tetanu
diphtheria
pneumococc
tickborn
enceph
vaccin
well
hepat
b
vaccin
correctli
cite
wolter
et
al
describ
elderli
peopl
determin
antibodi
level
recommend
elderli
peopl
vaccin
new
vaccin
previou
contact
common
basi
observ
appar
lie
find
involut
thymu
almost
complet
age
year
host
depend
cell
pool
gener
earlier
life
chang
cell
repertoir
eventu
observ
anoth
interest
observ
concern
rate
disappear
antibodi
two
phase
antibodi
declin
fast
slow
phase
observ
hepat
well
hepat
b
antibodi
respons
measur
quantit
result
may
differ
consider
depend
whether
blood
sampl
drawn
middl
fast
phase
slow
phase
remark
stress
also
perform
retrospect
studi
antibodi
respons
hepat
b
applic
combin
hepat
b
vaccin
twinrix
comparison
two
monoval
hepat
b
vaccin
g
antigen
content
younger
elderli
peopl
also
found
increas
age
antibodi
titer
immun
hepat
b
antigen
tend
lower
result
elderli
peopl
howev
differ
wolter
et
al
studi
editor
report
first
case
inflight
transmiss
passeng
probabl
sar
flight
attend
flight
new
york
frankfurtsingapor
march
time
admiss
diagnosi
made
epidemiolog
clinic
ground
diagnost
test
yet
avail
would
like
add
subsequ
perform
sar
serolog
posit
index
passeng
flight
attend
thu
confirm
inflight
transmiss
sar
serolog
also
posit
wife
index
passeng
howev
motherinlaw
neg
sar
serolog
later
clear
suffer
sar
preiser
w
person
commun
remain
unclear
motherinlaw
despit
prolong
close
contact
longhaul
flight
also
prior
flight
stay
new
york
later
hospit
frankfurt
develop
sar
wherea
flight
attend
infect
brief
contact
factor
determin
transmiss
suscept
sar
coronaviru
continu
constitut
import
area
research
editor
journal
vaccin
wolter
et
al
publish
paper
immunogen
combin
hepat
b
vaccin
elderli
peopl
retrospect
peopl
includ
femal
male
differ
age
indic
tabl
select
cohort
subject
follow
fix
time
without
take
account
mild
chronic
diseas
consid
person
appear
clinic
praxi
tabl
result
concern
age
differ
taken
account
differ
titer
statist
signific
except
hepat
b
vs
hepat
b
g
vaccin
age
group
year
seroprotect
rate
hepat
b
twinrix
definit
miuml
ident
wolter
et
al
year
year
year
year
studi
cite
correctli
wolter
et
al
experi
immun
respons
hepat
vaccin
good
age
group
year
data
shown
also
contrast
result
wolter
et
al
shown
howev
paper
strike
differ
find
wolter
et
al
concern
satisfactori
result
concern
respons
hepat
b
vaccin
elderli
question
ask
conflict
result
might
explain
exist
differ
phenotyp
cell
two
studi
popul
elderli
peopl
exclud
wolter
paper
even
paper
number
particip
high
enough
incorrectli
chosen
inject
site
deni
wolter
et
al
respect
differ
vaccin
lot
state
wolter
et
al
found
relationship
particular
batch
lack
immun
respons
batch
outdat
appear
reason
assum
failur
product
vaccin
usedinterrupt
cold
chain
mention
whether
rel
long
storag
serum
sampl
electr
blackout
took
place
reportedlow
level
hbsag
carriag
exclud
author
respect
health
problem
elderli
peopl
report
wolter
et
al
consider
proport
elderli
proband
kind
chronic
diseas
significantli
influenc
rate
protect
hepat
b
hepat
studi
elderli
peopl
includ
appear
clinic
praxi
without
regist
mild
health
aberr
may
differ
qualiti
popul
studi
wolter
et
al
studi
also
howev
interv
booster
draw
blood
sampl
differ
two
studi
shown
tabl
investig
blood
sampl
obtain
studi
within
month
booster
wherea
studi
wolter
et
al
mean
time
interv
complet
vaccin
measur
antibodi
titer
month
sinc
fast
phase
antibodi
declin
last
approxim
year
studi
might
enorm
quantit
impact
also
mention
paper
wolter
et
al
peopl
without
antihb
antibodi
longer
time
interv
vaccin
examin
serostatu
protect
titer
case
vaccin
failur
booster
effect
therefor
data
wolter
et
al
realist
relev
deni
relev
data
follow
consensu
statement
european
consensu
group
hepat
b
immun
need
booster
vaccin
success
primari
vaccin
seri
healthi
individu
mainten
hbsag
specif
memori
confer
protect
clinic
breakthrough
infect
even
absenc
detect
antibodi
effect
prime
appar
took
place
popul
wolter
et
al
sinc
booster
effect
moreov
hand
followup
antibodi
titer
mani
year
show
slow
phase
antibodi
declin
still
took
place
protect
rang
state
combin
hepat
b
twinrix
vaccin
effect
elderli
peopl
confirm
contrari
even
elderli
peopl
twinrix
induc
consider
better
immun
respons
two
monoval
hepat
b
vaccin
tabl
consequ
might
conclud
hepat
b
well
antigen
compromis
immun
respons
elderli
peopl
clinic
alarm
way
although
physiolog
agedepend
declin
may
observ
vaccin
twinrix
effect
mean
immun
popul
group
